3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
6
Inflammatory Bowel Diseases
3
Colonic Polyps
3
Colonic Neoplasms
3
Surgical Wound Infection
2
Neoplasms
2
Melanoma
2
Carcinoma, Hepatocellular
2
Uveal Melanoma
1
Sarcoma
1
Rectal Neoplasms
1
Polyps
1
Ovarian Neoplasms
1
Opioid-Induced Constipation
1
Lymphoma, Non-Hodgkin
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Intestinal Neoplasms
1
Gastrointestinal Hemorrhage
1
Diverticulitis
1
Cancer Pain
1
Adenoma
1
Interventions
Irinotecan
8
Bevacizumab
8
Fluorouracil
7
Leucovorin
6
Oxaliplatin
5
Capecitabine
4
5,10-methylenetetrahydrofolic acid
3
Radiotherapy
2
Levoleucovorin
2
Folfox protocol
2
Drug Therapy
2
Cetuximab
2
Bisacodyl
2
Aspirin
2
Artesunate
2
trametinib
1
spartalizumab
1
repotrectinib
1
pralsetinib
1
pembrolizumab
1
nazartinib
1
napabucasin
1
guadecitabine
1
encorafenib
1
canakinumab
1
camrelizumab
1
apatinib
1
alectinib
1
aldesleukin
1
XELOX
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Intestinal Neoplasms
×
Polyethylene Glycols
×
Clear all
NCT01887158
2014-06-17
PEGOP
Ospedale Santa Maria delle Croci
Phase 4
Completed
116 enrolled